Exponent (NASDAQ:EXPO) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Friday.
EXPO has been the topic of a number of other reports. Zacks Investment Research cut shares of Exponent from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 19th. SunTrust Banks reiterated a “hold” rating and issued a $77.00 target price on shares of Exponent in a research note on Thursday, October 19th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $82.00 price target on shares of Exponent in a research note on Sunday, November 5th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $80.00.
Exponent (NASDAQ:EXPO) opened at $70.70 on Friday. The firm has a market cap of $1,855.79, a PE ratio of 39.29 and a beta of 0.57. Exponent has a 52 week low of $55.75 and a 52 week high of $77.15.
In related news, CEO Paul R. Johnston sold 3,000 shares of the company’s stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $74.01, for a total transaction of $222,030.00. Following the sale, the chief executive officer now directly owns 32,342 shares in the company, valued at approximately $2,393,631.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Paul R. Johnston sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of $72.42, for a total transaction of $289,680.00. Following the sale, the chief executive officer now owns 38,394 shares in the company, valued at $2,780,493.48. The disclosure for this sale can be found here. Insiders have sold a total of 13,748 shares of company stock worth $996,740 over the last 90 days. 2.80% of the stock is currently owned by corporate insiders.
Institutional investors have recently bought and sold shares of the stock. SG Americas Securities LLC bought a new stake in Exponent during the 2nd quarter worth approximately $278,000. UBS Asset Management Americas Inc. increased its holdings in Exponent by 6.9% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 60,030 shares of the business services provider’s stock worth $3,500,000 after acquiring an additional 3,857 shares during the period. Nordea Investment Management AB increased its holdings in Exponent by 5.6% during the 3rd quarter. Nordea Investment Management AB now owns 32,461 shares of the business services provider’s stock worth $2,399,000 after acquiring an additional 1,712 shares during the period. Citadel Advisors LLC increased its holdings in Exponent by 70.1% during the 2nd quarter. Citadel Advisors LLC now owns 10,604 shares of the business services provider’s stock worth $618,000 after acquiring an additional 4,370 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in Exponent by 2.3% during the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock worth $12,249,000 after acquiring an additional 4,794 shares during the period. 88.61% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This piece of content was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://stocknewstimes.com/2017/12/15/exponent-expo-cut-to-sell-at-bidaskclub.html.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.